Stock Market Reviews

HTFL (HeartFlow, Inc.) News

Get the latest news, insights, and market updates on HTFL (HeartFlow, Inc.). Explore the news page 2 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• Portfolio Adjustment: Institutional Heavyweight Exits Biotech Stock
  Bain Capital completely exited its position in Disc Medicine stock during the third quarter
  Nov 19, 2025 - $HTFL
• Why Bain Capital Is Selling Shares of This Biotech Stock Now
  Bain Capital sold $20 million worth of Pharvaris stock during the third quarter.
  Nov 18, 2025 - $HTFL
• HeartFlow: Q3 Earnings Snapshot
  HTFL) on Wednesday reported a loss of $50.9 million in its third quarter. On a per-share basis, the Mountain View, California-based company said it had a loss of $1.04. Losses, adjusted for non-recurring costs and stock option expense, were 27 cents per share.
  Nov 12, 2025 - $HTFL
• Heartflow Reports Third Quarter 2025 Financial Results
  Initiates Full Year 2025 Revenue Guidance of $173.0 Million to $173.5 MillionMOUNTAIN VIEW, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in artificial intelligence (AI) technology for coronary artery disease (CAD), today reported financial results for the three months ended September 30, 2025. Third Quarter 2025 Highlights Total revenue of $46.3 million, a 41% increase year-over-yearGross margin of 76.5%, non-GAAP gross margin of 76.8%Net opera
  Nov 12, 2025 - $HTFL
• HeartFlow (HTFL): Evaluating Valuation After Recent Share Price Fluctuations
  HeartFlow (HTFL) shares have been edging lower over the past month, slipping 3% as the company continues to navigate market expectations. The current backdrop prompts investors to look closer at recent performance trends and fundamentals. See our latest analysis for HeartFlow. HeartFlow’s share price has seen some ups and downs, with a 13.3% share price return year-to-date. This indicates longer-term momentum remains in play, even after a steeper 5.6% slide just in the past day. Investors...
  Nov 10, 2025 - $HTFL
• AHA 2025: Late-Breaking Data Reinforce the Prognostic Power of AI-Driven Heartflow Plaque Analysis as the Most Clinically Validated Framework for Coronary Risk Stratification
  Multicenter outcomes FISH&CHIPS study of nearly 8,000 patients confirms total plaque volume as a powerful independent predictor of long-term cardiovascular events Heartflow Plaque Staging Personalizes Individual Cardiac Risk *Heartflow Plaque Analysis is an FDA-cleared device. Heartflow Plaque Staging is an investigational only framework and its safety and effectiveness have not been reviewed by the FDA. Overall Considerations 3. Tzimas, et al. JACC. 2023. https://doi.org/10.1016/j.jcmg.2023.05.
  Nov 9, 2025 - $HTFL
• Strong Investor Reception of IPO Boosted Heartflow (HTFL) in Q3
  Baron Funds, an investment management company, released its “Baron Health Care Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund rose 5.39% (Institutional Shares) in the quarter, compared to a 5.05% gain for the Russell 3000 Health Care Index (benchmark) and an 8.18% gain for the Russell 3000 […]
  Nov 4, 2025 - $HTFL
• Heartflow to Present Late-Breaking Data Advancing AI-Driven Heartflow Plaque Analysis at AHA 2025
  Data to highlight the precision of AI-powered Heartflow Plaque Staging framework in predicting long-term cardiovascular outcomesMOUNTAIN VIEW, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced it will present new late-breaking data highlighting the clinical and economic value of Heartflow Plaque Analysis at the American Heart Association (AHA) Scientific Sessions 2025, taking place
  Nov 3, 2025 - $HTFL
• Assessing HeartFlow After a 14% Weekly Surge and Expanding Tech Partnerships
  If HeartFlow stock is on your radar right now, you are not alone. The recent action in shares has sparked plenty of conversations among investors trying to decide whether that surge in value is just the beginning or a sign to be cautious. Over just the past week, HeartFlow popped up 14.2%, and in the last month, it has gained 25.1%. Year to date, the climb registers at an impressive 36.7%. It is clear that momentum has shifted in the company’s favor, attracting fresh attention from both...
  Oct 23, 2025 - $HTFL
• Heartflow to Report Third Quarter 2025 Financial Results on November 12, 2025
  MOUNTAIN VIEW, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced it will release financial results for the third quarter of 2025 after market close on Wednesday, November 12, 2025. Management will host a conference call to discuss financial results beginning at 1:30 p.m. PT / 4:30 p.m. ET on November 12, 2025. Those interested in listening to the conference call should register onli
  Oct 23, 2025 - $HTFL